| Literature DB >> 36233398 |
Cesar Leal-Costa1, Antonio Lopez-Villegas2, Mercedes Perez-Heredia3, Miguel Angel Baena-Lopez4, Carlos Javier Hernandez-Montoya5, Remedios Lopez-Liria6.
Abstract
(1) Background: Teledermatology (TD) has exponentially grown since the onset of COVID-19, as the Face-to-Face Dermatology (F-F/D) modality changed within Public Health Systems. Although studies have been conducted on health results, we did not find any that analyzed the experiences of individuals who received care through TD. Therefore, the main objective of the study was to analyze the experiences of dermatology patients and the communication with health personnel. (2)Entities:
Keywords: communication; dermatology; eHealth; experiences; information; telemedicine
Year: 2022 PMID: 36233398 PMCID: PMC9573490 DOI: 10.3390/jcm11195528
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Patient experiences and communication questionnaire.
| Items | Possible Answers |
|---|---|
| Q1. Did the clinicians talk to you in a way that was easy to understand? | 1 = Not at all; 2 = To a small extent; 3 = To a moderate extent; 4 = To a large extent; 5 = To a very large extent |
| Q2. Do you have confidence in the clinicians’ professional skills? | |
| Q3. Did you get sufficient information about your diagnosis/afflictions? | |
| Q4. Did you perceive the treatment as adapted to your situation? | |
| Q5. Were you involved in decisions regarding your treatment? | |
| Q6. Did you perceive the institution’s work as well organized? | |
| Q7. Did you have to wait before you were admitted for services at the institution? | |
| Q8. Overall, was the help and treatment you received at the institution satisfactory? | |
| Q9. Overall, what benefit have you had from the care at the institution? | |
| Q10. Do you believe that you were in any way given incorrect treatment? * | |
| Q11. I was asked questions in an aggressive manner * | 1 = Nothing; 2 = A little; 3 = Quite a bit; 4 = A lot; 5 = Very much |
| Q12. I was given answers in an aggressive manner * | |
| Q13. I was treated with kindness | |
| Q14. I was treated in a rude and hasty manner * | |
| Q15. The healthcare provider addressed me with a smile | |
| Q16. The healthcare provider was able to manage the consultation | |
| Q17. The healthcare provider showed respect for my privacy |
* Negative items.
Figure 1CONSORT Flow Diagram.
Selected patient baseline characteristics.
| All | Groups | |||
|---|---|---|---|---|
| Teledermatology | Face-to-Face Dermatology | |||
| Age M(SD) | 52.16 (19.97) | 52.53 (18.17) | 51.78 (21.65) | 0.744 a |
| Women | 240 (53.3%) | 131 (58.2%) | 109 (48.4%) | 0.047 b |
| Race/ethnicity | ||||
| White/Caucasian | 415 (92.22%) | 208 (94.4%) | 207 (92%) | 0.453 b |
| Gypsy | 6 (1.33%) | 4 (1.78%) | 2 (0.89%) | |
| Hispanic/Latino | 10 (2.22%) | 5 (2.22%) | 5 (2.22%) | |
| Black | 3 (0.67%) | 0 (0%) | 3 (1.33%) | |
| Arab | 16 (3.56%) | 8 (3.56%) | 8 (3.56%) | |
| Reason for consultation | ||||
| Injury | 232 (51.56%) | 140 (62.22%) | 92 (40.89%) | 0.000 b |
| Rash | 52 (11.56%) | 24 (10.67%) | 28 (12.44%) | |
| Injury and rash | 14 (3.11%) | 8 (%) | 6 (2.67%) | |
| Others * | 152 (33.78%) | 53 (23.56%) | 99 (44%) | |
| Diagnostic tests performed | ||||
| None | 363 (80.67%) | 211 (93.78%) | 152 (67.56%) | 0.000 b |
| Blood test | 31 (6.89%) | 7 (3.11%) | 24 (10.67%) | |
| Biopsy | 52 (11.56%) | 6 (2.67%) | 46 (20.44%) | |
| Micro punctures | 3 (0.67%) | 1 (0.44%) | 2 (0.89%) | |
| Anatomical location of the skin problem | ||||
| Trunk | 83 (18.5%) | 41 (18.2%) | 42 (18.8%) | 0.336 b |
| Limbs | 93 (20.7%) | 42 (18.7%) | 51 (22.8%) | |
| Head and neck | 210 (46.8%) | 113 (50.2%) | 97 (43.3%) | |
| Limbs. head and neck | 13 (2.9%) | 6 (2.7%) | 7 (3.1%) | |
| Trunk and limbs | 24 (5.3%) | 14 (6.2%) | 10 (4.5%) | |
| Whole body | 10 (2.2%) | 5 (2.2%) | 5 (2.2%) | |
| Trunk. head and neck | 16 (3.6%) | 4 (1.8%) | 12 (5.4%) | |
| Treatment | ||||
| Pharmacological | 246 (54.7%) | 146 (64.9%) | 100 (44.4%) | 0.000 b |
| Surgical | 123 (27.3%) | 31 (13.8%) | 92 (40.9%) | |
| Follow-up and evolution | 55 (12.2%) | 45 (20%) | 10 (4.4%) | |
| Pharmacological. surgical and follow-up | 26 (5.8%) | 3 (1.3%) | 23 (10.2%) | |
| Number of Primary Care visits M (SD) | 1.96 (0.76) | 2.24 (0.65) | 1.68 (0.76) | 0.000 a |
| Number of hospital visits M (SD) | 0.75 (0.95) | 0.01 (0.09) | 1.48 (0.85) | 0.000 a |
| Basic health zones | ||||
| El Ejido | 185 (41.11%) | 122 (54.22%) | 63 (28%) | 0.000 b |
| Adra | 46 (10.22%) | 29 (12.89%) | 17 (7.56%) | |
| Vícar | 35 (7.78%) | 9 (4%) | 26 (11.56%) | |
| Roquetas de Mar | 150 (33.33%) | 62 (27.56%) | 88 (39.11%) | |
| Berja | 34 (7.56%) | 3 (1.33%) | 31 (13.78%) | |
| Time required for assistance | ||||
| <1 h | 15 (3.3) | 15 (6.7) | 0 (0) | 0.000 b |
| 1–2 h | 164 (36.4) | 160 (71.1) | 4 (1.8) | |
| 2–3 h | 241 (53.6) | 49 (21.8) | 192 (85.3) | |
| 3–4 h | 30 (6.7) | 1 (0.4) | 29 (12.9) | |
| >4 h | 0 (0) | 0 (0) | 0 (0) | |
| Transportation used | ||||
| Public transport | 39 (8.7) | 16 (7.1) | 23 (10.2) | 0.000 b |
| Own car | 247 (54.9) | 97 (43.1) | 150 (66.7) | |
| Ambulance | 51 (11.3) | 17 (7.6) | 34 (15.1) | |
| Taxi | 9 (2) | 3 (1.3) | 6 (2.7) | |
| Other | 104 (23.1) | 92 (40.9) | 12 (5.3) | |
| Patient’s employment status | ||||
| Working | 156 (34.7) | 89 (39.6) | 67 (29.8) | 0.005 b |
| Unemployed | 94 (20.9) | 53 (23.6) | 41 (18.2) | |
| Pensioner | 143 (31.8) | 66 (29.3) | 77 (34.2) | |
| Sick leave | 11 (2.4) | 4 (1.8) | 7 (3.1) | |
| Other | 46 (10.2) | 13 (5.8) | 33 (14.7) | |
| Needs to be accompanied | ||||
| No | 166 (36.9) | 100 (44.4) | 66 (29.3) | 0.001 b |
| Yes | 284 (63.1) | 125 (55.6) | 159 (70.7) | |
| Accompanying employment | ||||
| Working | 72 (24.9) | 30 (22.7) | 42 (26.8) | 0.022 b |
| Unemployed | 140 (48.4) | 57 (43.2) | 83 (52.9) | |
| Pensioner | 67 (23.2) | 37 (28) | 30 (19.1) | |
| Sick leave | 4 (1.4) | 2 (1.5) | 2 (1.3) | |
| Other | 6 (2.1) | 6 (4.5) | 0 (0) | |
| Travel expenses | ||||
| No | 74 (16.4) | 51 (22.7) | 23 (10.2) | 0.000 b |
| Yes | 376 (83.6) | 174 (77.3) | 202 (89.8) | |
| Calls to Primary Care/Hospital | ||||
| Never | 365 (81.1) | 183 (81.3) | 182 (80.9) | 0.988 b |
| 1 | 49 (10.9) | 24 (10.7) | 25 (11.1) | |
| 2 | 36 (8) | 18 (8) | 18 (8) | |
| More than 2 times | 0 (0) | 0 (0) | 0 (0) | |
a t-Student test; b Chi Squared test; * The reason “Others” includes several dozens of different dermatologic pathologies that alone do not reach 2%. Because of the above, it was decided to include in the same group all dermatologic pathologies that did not reach at least 2%.
Figure 2Results derived from patient experiences and communication questionnaire. (a) Patient experiences items; ** p < 0.01; ‡ negative items; see Table 1 for the content of the items. (b) Communication items; ** p < 0.01, * p < 0.05; ‡ negative items; see Table 1 for the content of the items.